Stock Events

Stock Events

Kraig Biocraft Laboratories 

$0.111200
10
+$0.00+1.18% Tuesday 19:11

Statistics

Day High
0.1126
Day Low
0.1055
52W High
0.16
52W Low
0.07
Volume
473,708
Avg. Volume
-
Mkt Cap
120.19M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0008

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-6.8MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KBLB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bolt Biotherapeutics
BOLT
Mkt Cap8.76M
Bolt Biotherapeutics, Inc. is involved in biotechnology and drug development, competing in the broader biotech market.
CRISPR Therapeutics
CRSP
Mkt Cap4.9B
CRISPR Therapeutics AG specializes in gene editing, a technology that could be applied similarly to KBLB's genetic modification techniques.
Editas Medicine
EDIT
Mkt Cap383.65M
Editas Medicine, Inc. works on genome editing, directly competing with KBLB's genetic engineering approach.
Intellia Therapeutics
NTLA
Mkt Cap1.69B
Intellia Therapeutics, Inc. is a leader in CRISPR/Cas9 technology, offering competitive gene editing capabilities.
Pacific Biosciences of California
PACB
Mkt Cap406.89M
Pacific Biosciences of California, Inc. provides sequencing technologies, essential for genetic research like KBLB's.
Sangamo Therapeutics
SGMO
Mkt Cap62.14M
Sangamo Therapeutics, Inc. focuses on genomic medicine, competing in the genetic engineering space.
Syros Pharmaceuticals
SYRS
Mkt Cap2,683
Syros Pharmaceuticals, Inc. is involved in gene control, which is foundational to genetic engineering and biotech innovations.
Twist Bioscience
TWST
Mkt Cap4.74B
Twist Bioscience Corporation specializes in synthetic DNA, directly competing with KBLB's synthetic biology efforts.

About

Kraig Biocraft Laboratories, Inc. (KBLB) specializes in pioneering the creation of advanced protein-based fibers. Leveraging recombinant DNA technology, the company focuses on developing these materials for commercial deployment within the technical textile and specialty fiber sectors across the United States. Their innovative fibers find critical utility in demanding environments, including providing ballistic protection for military and law enforcement agencies, enhancing industrial applications like high-strength cables and impact-resistant components, fortifying safety equipment, and contributing to composite materials for the aerospace industry. Furthermore, KBLB's products are applicable across a wide array of markets such as medical textiles, geotextiles, defense and protective clothing, advanced filtration systems, textile-structured composites, functional and athletic wear, and specialized fabrics for construction and transportation uses. Established in 2006, Kraig Biocraft Laboratories, Inc. maintains its headquarters in Ann Arbor, Michigan.
Show more...
CEO
Mr. Kim Kraig Thompson
Employees
37
Country
United States
ISIN
US50075W1045

Listings

OTC Link
US
KBLB

0 Comments

Share your thoughts

FAQ

What is Kraig Biocraft Laboratories stock price today?▼
The current price of KBLB is $0.11 USD — it has increased by +1.18% in the past 24 hours. Watch Kraig Biocraft Laboratories stock price performance more closely on the chart.
What is Kraig Biocraft Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kraig Biocraft Laboratories stocks are traded under the ticker KBLB.
Is Kraig Biocraft Laboratories stock price growing?▼
KBLB stock has risen by +1.18% compared to the previous week, the month change is a -17.63% fall, over the last year Kraig Biocraft Laboratories has showed a +32.07% increase.
What is Kraig Biocraft Laboratories market cap?▼
Today Kraig Biocraft Laboratories has the market capitalization of 120.19M
What were Kraig Biocraft Laboratories earnings last quarter?▼
KBLB earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kraig Biocraft Laboratories revenue for the last year?▼
Kraig Biocraft Laboratories revenue for the last year amounts to 0 USD.
What is Kraig Biocraft Laboratories net income for the last year?▼
KBLB net income for the last year is -6.8M USD.
How many employees does Kraig Biocraft Laboratories have?▼
As of June 17, 2026, the company has 37 employees.
In which sector is Kraig Biocraft Laboratories located?▼
Kraig Biocraft Laboratories operates in the Materials sector.
When did Kraig Biocraft Laboratories complete a stock split?▼
The last stock split for Kraig Biocraft Laboratories was on May 28, 2009 with a ratio of 10:1.
Where is Kraig Biocraft Laboratories headquartered?▼
Kraig Biocraft Laboratories is headquartered in Ann Arbor, United States.